Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×

Virbac provides vets with reproductive educational resource following WSAVA guidelines publication

A sustained-release implant containing deslorelin and is licensed for use in sexually mature male dogs and cats from 3 months of age

The recently published WSAVA global guidelines in reproduction control highlight the latest science-based information on neutering and detail the potential benefits of non-surgical castration.

In response to the new scientific evidence and seismic shift in thinking on the current practices of neutering, Virbac is pleased to offer veterinary surgeons & veterinary nurses the opportunity to access a range of reproductive learning content covering key points of the WSAVA’s report and up-to-date information and advice. The summary of the report can be found here.

“There is so much new information coming through that vets need to assimilate,” said Dr Neil Mottram, technical manager at Virbac. “So the educational reproductive resource is designed to make that journey easier to navigate and provide vets with easy access to up-to-the-minute information on key issues in the report.”

The report highlights concerns about increasing moves to early neutering or for neutering to be used as a method of behavioural control, as not all aggressive behaviours are testosterone-related, so using a castration trial with long-acting GnRH agonist is recommended by the report before irreversible orchiectomy is performed. In addition, there is also evidence that gonadectomy may contribute to the development of some tumours, which is currently under intense investigation, as is the effect of age on castration

SUPRELORIN is a sustained-release implant containing deslorelin (a GnRH super agonist) and is licensed for use in sexually mature male dogs and cats from 3 months of age that have not been neutered to make them temporarily infertile. The implant is inserted subcutaneously under the loose skin on the back between the lower neck and the lumbar area. Conveniently, implantation is a quick procedure and does not require anaesthesia or hospitalisation.

SUPRELORIN is available in two presentations: a 4.7mg implant that lasts for at least 6 months and a 9.4mg implant that lasts for at least 12 months in dogs.

For more information on the new guidelines, the Virbac reproductive learning content and SUPRELORIN, or any of the other products in the Virbac reproduction portfolio, please speak to your Virbac territory manager.  

Have you heard about our
IVP Membership?

A wide range of veterinary CPD and resources by leading veterinary professionals.

Stress-free CPD tracking and certification, you’ll wonder how you coped without it.

Discover more